Management of cardiogenic shock complicating myocardial
infarction: an update 2019

J 2019

Management of cardiogenic shock complicating myocardial infarction: an update 2019

THIELE, H., E. M. OHMAN, S. DEWAHA-THIELE, U. ZEYMER, S. DESCH et. al.

Základní údaje

Originální název

Management of cardiogenic shock complicating myocardial infarction: an update 2019

Autoři

THIELE, H., E. M. OHMAN, S. DEWAHA-THIELE, U. ZEYMER a S. DESCH

Vydání

European heart journal, Oxford, Oxford University Press, 2019, 0195-668X

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30230 Other clinical medicine subjects

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

DAPT-SHOCK AMI

Impakt faktor

Impact factor: 22.673

Kód RIV

RIV/00216224:14110/19:00123181

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1093/eurheartj/ehz363

UT WoS

000490152600009

Klíčová slova česky

DAPT-SHOCK AMI; Shock; Heart failure; Treatment; Percutaneous coronary intervention; Myocardial infarction; Assist device

Klíčová slova anglicky

DAPT-SHOCK AMI; Shock; Heart failure; Treatment; Percutaneous coronary intervention; Myocardial infarction; Assist device

Štítky

Excelence Science, MU, RIV, UK LF PRAHA, user

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 10. 2. 2022 13:49, Bc. Hana Vladíková, BBA

Anotace

V originále

Dual Antiplatelet Therapy for Shock patients with Acute Myocardial Infarction (DAPT-SHOCK-AMI) trial (ClinicalTrials.gov: NCT03551964). Cardiogenic shock (CS) remains the most common cause of death in patients admitted with acute myocardial infarction (AMI) and mortality remained nearly unchanged in the range of 40-50% during the last two decades. Early revascularization, vasopressors and inotropes, fluids, mechanical circulatory support, and general intensive care measures are widely used for CS management. However, there is only limited evidence for any of the above treatment strategies except for revascularization and the relative ineffectiveness of intra-aortic balloon pumping. This updated review will outline the management of CS complicating AMI with major focus on state-of-the art treatment.

Návaznosti

90090, velká výzkumná infrastruktura

Název: CZECRIN II

Citovat

THIELE, H., E. M. OHMAN, S. DEWAHA-THIELE, U. ZEYMER a S. DESCH. Management of cardiogenic shock complicating myocardial infarction: an update 2019. European heart journal. Oxford: Oxford University Press, 2019, roč. 40, č. 32, s. "2671"-"+", 15 s. ISSN 0195-668X. Dostupné z: https://dx.doi.org/10.1093/eurheartj/ehz363.

@article{1808359,
   author = {Thiele, H. and Ohman, E. M. and deWahaandThiele, S. and Zeymer, U. and Desch, S.},
   article_location = {Oxford},
   article_number = {32},
   doi = {http://dx.doi.org/10.1093/eurheartj/ehz363},
   keywords = {DAPT-SHOCK AMI; Shock; Heart failure; Treatment; Percutaneous coronary intervention; Myocardial infarction; Assist device},
   language = {eng},
   issn = {0195-668X},
   journal = {European heart journal},
   note = {DAPT SHOCK AMI (Prague-23)},
   title = {Management of cardiogenic shock complicating myocardial infarction: an update 2019},
   url = {https://academic.oup.com/eurheartj/article/40/32/2671/5528526},
   volume = {40},
   year = {2019}
}

TY  - JOUR
ID  - 1808359
AU  - Thiele, H. - Ohman, E. M. - deWaha-Thiele, S. - Zeymer, U. - Desch, S.
PY  - 2019
TI  - Management of cardiogenic shock complicating myocardial infarction: an update 2019
JF  - European heart journal
VL  - 40
IS  - 32
SP  - "2671"-"+"
EP  - "2671"-"+"
PB  - Oxford University Press
SN  - 0195668X
N1  - DAPT SHOCK AMI (Prague-23)
KW  - DAPT-SHOCK AMI
KW  - Shock
KW  - Heart failure
KW  - Treatment
KW  - Percutaneous coronary intervention
KW  - Myocardial infarction
KW  - Assist device
UR  - https://academic.oup.com/eurheartj/article/40/32/2671/5528526
N2  - Dual Antiplatelet Therapy for Shock patients with Acute Myocardial Infarction (DAPT-SHOCK-AMI) trial (ClinicalTrials.gov: NCT03551964). Cardiogenic shock (CS) remains the most common cause of death in patients admitted with acute myocardial infarction (AMI) and mortality remained nearly unchanged in the range of 40-50% during the last two decades. Early revascularization, vasopressors and inotropes, fluids, mechanical circulatory support, and general intensive care measures are widely used for CS management. However, there is only limited evidence for any of the above treatment strategies except for revascularization and the relative ineffectiveness of intra-aortic balloon pumping. This updated review will outline the management of CS complicating AMI with major focus on state-of-the art treatment.
ER  -

THIELE, H., E. M. OHMAN, S. DEWAHA-THIELE, U. ZEYMER a S. DESCH. Management of cardiogenic shock complicating myocardial infarction: an update 2019. \textit{European heart journal}. Oxford: Oxford University Press, 2019, roč.~40, č.~32, s.~''2671''-''+'', 15 s. ISSN~0195-668X. Dostupné z: https://dx.doi.org/10.1093/eurheartj/ehz363.

Podrobný výpis o publikaci